AYTU BIOPHARMA, INC Balance Sheet
AYTU|12 years of annual SEC 10-K data (FY2012-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 12 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$124M
FY2025
Cash
$31M
Cash and equivalents
Total Debt
$11M
FY2025
Shareholder Equity
$19M
FY2025
AYTU BIOPHARMA, INC had $124M in total assets and $19M in shareholders' equity as of FY2025. Total debt was $11M against $31M in cash, resulting in a $20M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
- Negative return on equity: -71.5% ROE
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2018 | FY2017 | FY2016 | FY2015 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $31.0M | $20.0M | $23.0M | $19.4M | $49.6M | $48.1M | $7.0M | $802.3K | $8.1M | $7.4M | $2.9M | - |
| Accounts Receivable | $31.2M | $23.5M | $28.9M | $21.7M | $28.2M | $5.6M | $578.8K | $528.0K | $162.4K | $157.1K | - | - |
| Inventory | $11.4M | $12.1M | $12.0M | $10.8M | $16.3M | $10.0M | $1.3M | $1.3M | $524.7K | $39.4K | - | - |
| Current Assets | $79.2M | $61.9M | $72.8M | $59.9M | $105.2M | $75.4M | $9.5M | $3.0M | $10.1M | $8.0M | $1.9K | $186 |
| PP&E (Net) | $532.0K | $693.0K | $1.8M | - | - | $258.5K | $218.7K | $647.3K | $231.4K | $29.7K | $7.5K | $12.5K |
| Goodwill | - | - | $0 | $0 | $65.8M | $28.1M | - | $238.4K | $221.0K | $74.0K | - | - |
| Total Assets | $124.2M | $118.1M | $136.5M | $137.6M | $265.7M | $153.3M | $21.1M | $15.0M | $24.3M | $18.2M | $9.7K | $12.6K |
| Current Liabilities | $63.1M | $62.2M | $69.0M | $64.4M | $109.4M | $28.8M | $3.4M | $3.6M | $10.1M | $1.5M | $120.5K | $82.4K |
| Total Debt | $10.9M | $10.9M | $15.0M | $15.0M | - | - | - | - | - | - | - | - |
| Shareholders' Equity | $19.0M | $27.7M | $39.4M | $44.3M | $137.6M | $95.0M | $13.4M | $4.0M | $10.1M | $15.6M | $9.8M | -$69.7K |